Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia
1 other identifier
interventional
1
1 country
1
Brief Summary
This is an investigator initiated prospective study to determine whether the use of a negative pressure suction in the hypopharynx will reduce the amount of aspiration during Video Fluoroscopic Swallowing Exam (VFSE) among patients with oropharyngeal dysphagia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2016
CompletedFirst Submitted
Initial submission to the registry
October 29, 2017
CompletedFirst Posted
Study publicly available on registry
December 11, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2025
CompletedApril 9, 2026
April 1, 2026
2 months
October 29, 2017
April 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Degree of aspiration
Degree of aspiration or laryngeal penetration, evaluated by the validated Rosenbek Penetration-Aspiration Scale (PAS). The PAS scale is an 8-point (1 to 8), equal-appearing interval scale: 1. Material does not enter airway 2. Material enters the airway, remains above the vocal folds, and is ejected from the airway. 3. Material enters the airway, remains above the vocal folds, and is not ejected from the airway. 4. Material enters the airway, contacts the vocal folds, and is ejected from the airway. 5. Material enters the airway, contacts the vocal folds, and is not ejected from the airway. 6. Material enters the ariway, passes below the vocal folds, and is ejected into the larynx or out of the airway. 7. Material enters the airway, passes below the vocal folds, and is not ejected from the trachea despite effort. 8. Material enters the airway, passes below the vocal folds, and no effort is made to eject.
During VFSE, from the beginning of administration of the first bolus size to completion of the VFSE
Pharyngo-esophageal Segment (PES) opening size
Pharyngo-esophageal Segment (PES) is a 2.5 to 4.5 cm manometric high-pressure zone located between the pharynx and esophagus. Normal Pharyngoesophageal segment opening size on lateral view: 0.80 cm +/- 0.40 cm
During VFSE, PES is measured when the patient administers 20 cc of liquid barium and the PES is maximally distended.
Secondary Outcomes (3)
Pharyngeal Constriction Ratio (PCR)
Measurement of the pharyngeal area during maximum contraction are taken after administration of 20 cc liquid barium. The pharyngeal area at rest is measured when 1 cc bolus is held in the oral cavity.
Oropharyngeal transit time
Time from when bolus head first passes posterior nasal spine to time bolus head enters base of vallecula
Hypopharyngeal transit time
Time from when bolus head exits the vallecula to time when bolus tale exits PES
Study Arms (1)
Negative Pressure Suction Device
EXPERIMENTALInterventions
The negative pressure suction device to be used in the study will be a Foley catheter. The catheter will be placed through the gastrostomy tube site, directed retrograde through the esophagus, and terminating in the PES.
Eligibility Criteria
You may qualify if:
- Patients with videofluoroscopic evidence of aspiration with Rosenbek Penetration Aspiration Scale (PAS) greater than 5 for all tested food consistencies
- Gastrostomy tube dependence
- Exhaustion of conventional treatment options (physical, medical, and surgical therapies)
You may not qualify if:
- Complete PES stricture
- Inability to follow commands
- Current malignant disease
- No gastrostomy tube present
- Less than two years of cancer-free survival (if applicable)
- Vulnerable populations: adults unable to consent, pregnant women, and prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC Davis Medical Center
Sacramento, California, 95817, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2017
First Posted
December 11, 2017
Study Start
January 30, 2016
Primary Completion
April 13, 2016
Study Completion
December 9, 2025
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share